MTOR and pancreatic neoplasm: To determine whether BIA is effective against HT1080, PANC-1 pancreatic cancer cells resistant to mTOR inhibitor, and other pancreatic cancer cells including Capan-1 and MIA PaCa-2 cells, we compared with mTOR inhibitors such as AZD8055, INK128, Omipalisib, OSI-027, and Voxtalisib.